NeuroDerm Ltd. Ordinary Shares
NDRM
NDRM was delisted on the 17th of October, 2017.
73 hedge funds and large institutions have $418M invested in NeuroDerm Ltd. Ordinary Shares in 2017 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 29 increasing their positions, 16 reducing their positions, and 12 closing their positions.
1,497% more call options, than puts
Call options by funds: $7.89M | Put options by funds: $494K
81% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 16
25% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 12
18% more capital invested
Capital invested by funds: $354M → $418M (+$64M)
4% more funds holding
Funds holding: 70 → 73 (+3)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$18.4M |
| 2 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$12M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$9.65M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$5.62M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$3.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$14.1M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$9.77M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$9.56M |
| 4 |
Millennium Management
New York
|
-$6.32M |
| 5 |
CLCM
Crawford Lake Capital Management
Lakewood,
New Jersey
|
-$4.57M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
D.E. Shaw & Co
New York
| – | -$1.79M | -67,391 | Closed |
|
|
HCMT
77
Highland Capital Management (Texas)
Dallas,
Texas
| – | -$1.59M | -60,000 | Closed |
|
78
Group One Trading
Chicago,
Illinois
| – | -$1.06M | -41,083 | Closed |
|
79
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$823K | -31,765 | Closed |
|
80
Goldman Sachs
New York
| – | -$351K | -13,236 | Closed |
|
81
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$266K | -10,000 | Closed |
|
82
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
| – | -$89K | -3,360 | Closed |
|
|
PCM
83
Penserra Capital Management
Orinda,
California
| – | -$68K | -2,590 | Closed |
|
|
FPF
84
FNY Partners Fund
New York
| – | -$66K | -2,500 | Closed |
|
85
Creative Planning
Overland Park,
Kansas
| – | -$27K | -1,000 | Closed |
|
NDRM Hedge Fund Activity: Q2 2017 in Review
73 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q2 2017, worth a combined $418M — up 18% from $354M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new NDRM positions and 12 closed out — a net gain of 3 holders — while 29 added to existing stakes and 16 trimmed.
The largest buyer was Viking Global Investors, opening a new position worth an estimated $18.4M. The largest seller was Avoro Capital Advisors, cutting an estimated $14.1M.
- 73 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q2 2017, up from 70 in Q1 2017.
- Funds reported $418M of NeuroDerm Ltd. Ordinary Shares stock for Q2 2017, up 18% quarter-over-quarter.
- 15 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q2 2017 and 12 closed out, a net change of +3 holders.
- The largest NeuroDerm Ltd. Ordinary Shares buyer in Q2 2017 was Viking Global Investors, an estimated $18.4M added.
- The largest NeuroDerm Ltd. Ordinary Shares seller in Q2 2017 was Avoro Capital Advisors, an estimated $14.1M sold.
Based on aggregated 13F filings for Q2 2017.